Angiopoietin-1 protects endothelial cells from hypoxia-induced apoptosis via inhibition of phosphatase and tensin homologue deleted from chromosome ten

Korean Circulation Journal

Volumn 39, Issue 2, 2009, Pages 57-65

  Lee, Sae Won ^a,b   Youn, Seock Won ^a   Kim, Tae Youn ^a   Suh, Jung Won ^a   Koh, Gou Young ^d   Kwon, Yoo Wook ^a   Chae, In Ho ^a,c   Park, Young Bae ^a   Kim, Hyo Soo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Angiopoietin 1; Cell cycle; Hypoxia; Ischemia

Indexed keywords

ANGIOPOIETIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P27; TRANSCRIPTION FACTOR FKHR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 61849104773     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.2.57     Document Type: Article

References (26)

1. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000;100:387-90.
2. Li DM, Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 1998;95:15406-11.
3. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G, Stokoe D. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 1998,8:1195-8.
4. Yah X, Fraser M, Qiu Q, Tsang BK. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner Gynecol Oncol 2006;102:348-55.
5. Delgado-Esteban M, Martin-Zanca D, Andres-Martin L, Almeida A, Bolaños JP. Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3-kinase/Akt neuroprotective signaling pathway J Neurochem 2007,102:194-205.
6. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-93.
7. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8.
8. Kim H J, Kim DK. Angiogenic gene therapy in patients with ischemic cardiovascular diseases. Korean Circ J 2003;33:7-14.
9. Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 2003; 9.900-6.
10. Nag S. The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model. Trends Mol Med 2002;8:38-44.
11. Cho CH, Kammerer RA, Lee H J, et al. Designed angiopoietin-1 variant, COMP-Angl, protects against radiation-induced endothelial cell apoptosis. Proc Natl Acad Sci USA 2004;101:5553-8.
12. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA. Angiopoietin-1 promotes cardiac and skeletal myocyte survival throuth integrins. Circ Res 2005;96:e8-24.
13. Park SJ, Kim DH, Seo JB, et al. Thalidomide as apotent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery Korean Circ J 2004;34:346-55.
14. Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G, Eck MJ. Structural basis for negative regulation of hypoxia-inducible factor-1 alpha by CITED2. Nat Struct Biol 2003;10:504-12.
15. Hwang KK, Kim HS, Seo JU, et al. Apoptosis in the human neonatal vascular remodeling. Korean Cite J 2001;31:681-700.
16. Choi YK, Kim JH, Kim WJ, et al. AKAP12 regulates human blood-retinal barrier formation by downregulation of hypoxiainducible factor-1 alpha. J Neurosci 2007;27:4472-81.
17. Chandrasekar B, Valente AJ, Freeman GL, Mahimainathan L, Mummidi S. Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappa-Bdependent PTEN activation. Biochem Biophys Res Commun 2006; 339:956-63.
18. Ryan S, McNicholas WT, Taylor CT. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun 2007;355:728-33.
19. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54.
20. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN Mol Cell Biol 2000; 20:8969-82.
21. Harfouche R, Hasséssian HM, Guo Y, et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 2002;64:135-47.
22. Morris JB, Kenney B, Huynh H, Woodcock EA. Regulation of the proapoptotie factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists. Endocrinology 2005;146:4370-6.
23. Lee HY, Chung JW, Youn SW, et al. Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2007;100: 372-80.
24. Medema RH, Kops GJ, Bos JL, Burgering BM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000;404:782-7.
25. Takahashi K, Ito Y, Morikawa M, et al. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol Ther 2003;8.584-92.
26. Jung H, Gurunluoglu R, Scharpf J, Siemionow M. Adenovirusmediated angiopoietin-1 gene therapy enhances skinflap survival. Microsurgery 2003;23:374-80.